ICYMI: Fighting for a cure to ALS
Yesterday at The Atlantic Festival, I had the chance to speak with Amy, a biopharmaceutical researcher focused on amyotrophic lateral sclerosis (ALS).
Yesterday at The Atlantic Festival, I had the chance to speak with Amy, a biopharmaceutical researcher focused on amyotrophic lateral sclerosis (ALS).
Yesterday at The Atlantic Festival, I had the chance to speak with Amy, a biopharmaceutical researcher focused on amyotrophic lateral sclerosis (ALS). As a young girl, Amy’s father inspired her to become a scientist. Years later, his ALS diagnosis made her life’s work personal.
Watch our conversation about the challenges of finding an ALS treatment and the hope we have in research and development. As our payment system evolves, it’s crucial that innovative medicines are accessible and affordable for the patients who need them.